Skip to content

Comparison of endoscopic therapy and TIPS in patients with portal vein thrombosis in cirrhosis combined with esophageal variceal bleeding

Comparison of endoscopic therapy and TIPS in patients with portal vein thrombosis in cirrhosis combined with esophageal variceal bleeding

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200058923
Enrollment
Unknown
Registered
2022-04-20
Start date
2022-05-01
Completion date
Unknown
Last updated
2024-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cirrhotic esophageal varices with portal vein thrombosis

Interventions

Group 1:Endoscopic treatment of esophageal varices
Group 2:Transjugular intrahepatic portosystemic shunt

Sponsors

The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 18 and 75 years; 2. After medical history inquiry, laboratory examination, endoscopy, liver color ultrasound, enhanced CT and MRI, the patient was diagnosed as cirrhotic portal vein thrombosis complicated with esophageal varices rupture and bleeding; 3. Endoscopic therapy or TIPS was first performed.

Exclusion criteria

Exclusion criteria: 1. Patients with blood system diseases; 2. Patients with other severe organ complications and malignant tumors other than those conforming to Milan international standards; 3. No regular follow-up and treatment; 4. Bleeding in other places.

Design outcomes

Primary

MeasureTime frame
Recurrent bleeding;Survival rate;Overt hepatic encephalopathy;Vascular recanalization;

Secondary

MeasureTime frame
Other complications of portal hypertension and postoperative adverse effects;

Countries

China

Contacts

Public ContactKong Derun
kongderun168@163.com+86 13955155476

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026